204 related articles for article (PubMed ID: 23977840)
21. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
Wober W; Diez Crespo CD; Bähre M
Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
[TBL] [Abstract][Full Text] [Related]
22. Azelastine and olopatadine in the treatment of allergic rhinitis.
Kaliner MA
Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
[TBL] [Abstract][Full Text] [Related]
24. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
25. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
Lee TA; Pickard AS
Pharmacotherapy; 2007 Jun; 27(6):852-9. PubMed ID: 17542768
[TBL] [Abstract][Full Text] [Related]
27. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?
Keith PK; Scadding GK
Curr Med Res Opin; 2009 Aug; 25(8):2021-41. PubMed ID: 19569975
[TBL] [Abstract][Full Text] [Related]
28. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
29. A novel and effective approach to treating rhinitis with nasal antihistamines.
Kaliner MA
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):383-90; quiz 391-2, 418. PubMed ID: 18051206
[TBL] [Abstract][Full Text] [Related]
30. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
Haahr PA; Jacobsen C; Christensen ME
Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
[TBL] [Abstract][Full Text] [Related]
31. A review of the use of fluticasone furoate since its launch.
Villa E; Magnoni MS; Micheli D; Canonica GW
Expert Opin Pharmacother; 2011 Sep; 12(13):2107-17. PubMed ID: 21797803
[TBL] [Abstract][Full Text] [Related]
32. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?
Yawn B
MedGenMed; 2006 Jan; 8(1):23. PubMed ID: 16915153
[TBL] [Abstract][Full Text] [Related]
33. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
[TBL] [Abstract][Full Text] [Related]
34. New therapeutic options for allergic rhinitis: back to the future with intranasal corticosteroid aerosols.
Carr WW
Am J Rhinol Allergy; 2013; 27(4):309-13. PubMed ID: 23816748
[TBL] [Abstract][Full Text] [Related]
35. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
Esteitie R; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):155-61. PubMed ID: 20674827
[TBL] [Abstract][Full Text] [Related]
36. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
[TBL] [Abstract][Full Text] [Related]
37. The role of intranasal corticosteroids in the management of pediatric allergic rhinitis.
Kaari J
Clin Pediatr (Phila); 2006 Oct; 45(8):697-704. PubMed ID: 16968954
[TBL] [Abstract][Full Text] [Related]
38. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.
Blaiss MS
Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
[TBL] [Abstract][Full Text] [Related]
40. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
Grossman J; Halverson PC; Meltzer EO; Shoenwetter WF; van Bavel JH; Woehler TR; Freitag JJ; Hemsworth GR
Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
